Literature DB >> 139219

Chemotherapy of gastrointestinal cancer.

C G Moertel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 139219

Source DB:  PubMed          Journal:  Clin Gastroenterol        ISSN: 0300-5089


× No keyword cloud information.
  12 in total

1.  Bilateral total corneal epithelial erosion as a side effect of cytotoxic therapy.

Authors:  A Hirsh; A Alhalel; A Weiss; H Brener; I Avni
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

2.  Palliative and adjunctive measures in rectal cancer.

Authors:  A Fritsch; W Seidl; C Walzel; K Moser; R Schiessel
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

3.  Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma.

Authors:  P H Konits; M J Egorin; D A Van Echo; J Aisner; P A Andrews; M E May; N R Bachur; P H Wiernik
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 4.  Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010.

Authors:  Chakshu Sharma; Karim M Eltawil; Paul D Renfrew; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

Review 5.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the stomach and carcinoid tumors.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-07       Impact factor: 1.798

Review 6.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the pancreas.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-06       Impact factor: 1.798

7.  Chemotherapy in advanced gastric cancer: a controlled, prospective, randomised multi-centre study.

Authors:  M O Rake; C N Mallinson; J B Cocking; M T Cwynarski; C A Fox; V J Wass; B L Diffey; G A Jackson
Journal:  Gut       Date:  1979-09       Impact factor: 23.059

8.  Chemotherapy of chemically-induced colorectal tumours.

Authors:  J M Gilbert; E M Thompson; G Slavin; A E Kark
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 5.344

9.  Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug.

Authors:  J Cummings; C S McArdle
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

10.  A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer.

Authors:  T R Evans; F J Lofts; J L Mansi; J P Glees; A G Dalgleish; M J Knight
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.